| Literature DB >> 30191134 |
Md Tawhid Hossain1, Ummehani Hassi1, S M Imamul Huq2.
Abstract
This study aimed to assess the concentrations of heavy metal ('lead (Pb)''cadmium (Cd)', and 'chromium (Cr)') in various brands of four types of tobacco products (zarda, gul, cigarettes, and bidi) as well as calculate toxicological risk as a lifetime cancer risk for Pb, Cd, and Cr. In smokeless tobacco products, the metal concentration ranged from 0.99 to 10.02 μg/g for Pb, 1.05-3.53 μg/g for Cd, and 1.23-7.29 μg/g for Cr, respectively. Metal concentrations in the smoke-based tobacco products ranged from 0.98 to 3.07 μg/g for Pb, 0.91-3.46 μg/g for Cd, 1.08-6.75 μg/g for Cr, respectively. When assuming a 100% transfer of these metals, the calculated lifetime cancer risk was found 'unacceptable' in 33 out of 35 tobacco samples which exceeded the U.S. Environmental Protection Agency (USEPA) benchmark of an 'acceptable' cancer risk range of 10E-4 to 10E-6. Our study demonstrated higher levels of Pb, Cd, and Cr in various tobacco products of Bangladesh compared to GOTHIATEK standard. This study shows the need for the development of industry standards and regulation for tobacco products to reduce the levels of heavy metals.Entities:
Keywords: Bangladesh; CEPA, California Environmental Protection Agency; Heavy metals; IARC, International Agency for Research on Cancer; ITC, international tobacco control; Lifetime cancer risk; Smoke-based and smokeless tobacco; USEPA, U.S. Environmental Protection Agency; WHO, World Health Organization
Year: 2018 PMID: 30191134 PMCID: PMC6125795 DOI: 10.1016/j.toxrep.2018.08.019
Source DB: PubMed Journal: Toxicol Rep ISSN: 2214-7500
Concentration of Pb, Cd, and Cr in Smokeless and Smoke-based Tobacco Products.
| Smokeless tobacco | Pb | Cd | Cr | |
|---|---|---|---|---|
| SLT-1 | 10.02 ± 0.03 | 1.08 ± 0.03 | 1.34 ± 0.15 | |
| SLT-2 | 7.39 ± 0.11 | 2.05 ± 0.09 | 1.23 ± 0.20 | |
| SLT-3 | 1.30 ± 0.03 | 1.37 ± 0.02 | 3.19 ± 0.18 | |
| SLT-4 | 2.16 ± 0.14 | 3.21 ± 0.20 | 5.20 ± 0.25 | |
| SLT-5 | 0.99 ± 0.04 | 2.49 ± 0.03 | 1.85 ± 0.07 | |
| SLT-6 | 2.33 ± 0.16 | 1.22 ± 0.06 | 2.66 ± 0.10 | |
| SLT-7 | 1.54 ± 0.06 | 2.78 ± 0.07 | 3.22 ± 0.12 | |
| SLT-8 | 2.78 ± 0.06 | 2.49 ± 0.16 | 1.30 ± 0.12 | |
| SLT-9 | 3.29 ± 0.21 | 1.29 ± 0.11 | 2.14 ± 0.13 | |
| SLT-10 | 2.85 ± 0.07 | 1.39 ± 0.01 | 3.73 ± 0.10 | |
| SLT-11 | 1.08 ± 0.08 | 1.08 ± 0.00 | 1.75 ± 0.11 | |
| SLT-12 | 1.13 ± 0.03 | 3.12 ± 0.15 | 7.29 ± 0.03 | |
| SLT-13 | 2.02 ± 0.12 | 1.23 ± 0.21 | 1.80 ± 0.09 | |
| SLT-14 | 1.65 ± 0.14 | 3.53 ± 0.08 | 1.58 ± 0.07 | |
| SLT-15 | 2.67 ± 0.11 | 1.40 ± 0.01 | 1.36 ± 0.02 | |
| SLT-16 | 1.74 ± 0.07 | 3.06 ± 0.17 | 4.35 ± 0.07 | |
| SLT-17 | 1.16 ± 0.00 | 1.57 ± 0.05 | 6.01 ± 0.13 | |
| SLT-18 | 1.54 ± 0.06 | 1.68 ± 0.12 | 1.71 ± 0.15 | |
| SLT-19 | 1.57 ± 0.13 | 1.92 ± 0.03 | 5.73 ± 0.22 | |
| SLT-20 | 1.61 ± 0.15 | 1.05 ± 0.03 | 3.55 ± 0.09 | |
Estimated Cancer risk of Smokeless Tobacco Products.
| Smokeless tobacco | Pb Cancer Risk Upon 100% Transfer | Pb | Cd Cancer Risk Upon 100% Transfer | Cd Cancer Risk Upon 6% Transfer | Cr Cancer Risk Upon 100% Transfer | Over all Cancer Risk Upon 100% Transfer | Over all Cancer Risk upon reduced Transfer | |
|---|---|---|---|---|---|---|---|---|
| SLT-1 | 6.33E-06 | 3.80E-07 | 1.21E-03 | 7.25E-05 | 4.17E-05 | 1.26E-03 | 1.15E-04 | |
| SLT-2 | 4.67E-06 | 2.80E-07 | 2.28E-03 | 1.37E-04 | 3.84E-05 | 2.33E-03 | 1.76E-04 | |
| SLT-3 | 8.18E-07 | 4.91E-08 | 1.53E-03 | 9.19E-05 | 9.96E-05 | 9.96E-05 | 1.92E-04 | |
| SLT-4 | 1.37E-06 | 8.20E-08 | 3.58E-03 | 2.15E-04 | 1.62E-04 | 3.74E-03 | 3.77E-04 | |
| SLT-5 | 6.28E-07 | 3.77E-08 | 2.78E-03 | 1.67E-04 | 5.79E-05 | 2.83E-03 | 2.24E-04 | |
| SLT-6 | 1.47E-06 | 8.84E-08 | 1.36E-03 | 8.18E-05 | 8.29E-05 | 1.45E-03 | 1.65E-04 | |
| SLT-7 | 9.70E-07 | 5.82E-08 | 3.10E-03 | 1.86E-04 | 1.00E-04 | 3.20E-03 | 2.86E-04 | |
| SLT-8 | 1.75E-06 | 1.05E-07 | 8.79E-02 | 5.27E-03 | 4.05E-05 | 8.80E-02 | 5.32E-03 | |
| SLT-9 | 2.08E-06 | 1.25E-07 | 5.39E-02 | 3.23E-03 | 6.68E-05 | 5.40E-02 | 3.30E-03 | |
| SLT-10 | 1.80E-06 | 1.08E-07 | 1.09E-01 | 6.52E-03 | 1.16E-04 | 1.09E-01 | 6.63E-03 | |
| SLT-11 | 6.79E-07 | 4.07E-08 | 1.21E-03 | 7.25E-05 | 5.47E-05 | 1.26E-03 | 1.27E-04 | |
| SLT-12 | 7.13E-07 | 4.28E-08 | 1.10E-01 | 6.61E-03 | 2.27E-04 | 1.10E-01 | 6.84E-03 | |
| SLT-13 | 1.28E-06 | 7.65E-08 | 6.16E-02 | 3.69E-03 | 5.60E-05 | 6.16E-02 | 3.75E-03 | |
| SLT-14 | 1.04E-06 | 6.24E-08 | 3.93E-03 | 2.36E-04 | 4.93E-05 | 3.98E-03 | 2.85E-04 | |
| SLT-15 | 1.68E-06 | 1.01E-07 | 1.56E-03 | 9.38E-05 | 4.23E-05 | 4.40E-05 | 1.36E-04 | |
| SLT-16 | 1.10E-06 | 6.60E-08 | 1.36E-01 | 8.17E-03 | 1.36E-04 | 1.36E-01 | 8.31E-03 | |
| SLT-17 | 7.34E-07 | 4.40E-08 | 7.87E-02 | 4.72E-03 | 1.87E-04 | 7.89E-02 | 4.91E-03 | |
| SLT-18 | 9.70E-07 | 5.82E-08 | 4.21E-02 | 2.53E-03 | 5.33E-05 | 4.22E-02 | 3.59E-03 | |
| SLT-19 | 9.94E-07 | 5.96E-08 | 6.07E-02 | 3.64E-03 | 1.79E-04 | 6.08E-02 | 2.58E-03 | |
| SLT-20 | 1.02E-06 | 6.09E-08 | 5.83E-02 | 3.50E-03 | 8.92E-05 | 5.84E-02 | 3.82E-03 | |
Estimated Cancer risk of Smoke Based Tobacco Products.
| Smoke based tobacco | Pb | Pb Cancer Risk Upon 6% Transfer | Cd Cancer Risk Upon 100% Transfer | Cd Cancer Risk Upon 20% Transfer | Cr Cancer Risk Upon 100% Transfer | Over all Cancer Risk Upon 100% Transfer | Over all Cancer Risk Reduced Transfer | |
|---|---|---|---|---|---|---|---|---|
| SBT-1 | 3.34E-06 | 2.01E-07 | 1.55E-03 | 3.11E-04 | 4.62E-02 | 4.78E-02 | 4.65E-02 | |
| SBT-2 | 4.57E-06 | 2.74E-07 | 1.18E-03 | 2.36E-04 | 1.43E-01 | 1.44E-01 | 1.43E-01 | |
| SBT-3 | 6.58E-06 | 3.95E-07 | 1.04E-03 | 2.09E-04 | 4.63E-02 | 4.73E-02 | 4.65E-02 | |
| SBT-4 | 4.68E-06 | 2.81E-07 | 1.02E-03 | 2.03E-04 | 6.60E-02 | 6.70E-02 | 6.62E-02 | |
| SBT-5 | 3.82E-06 | 2.29E-07 | 1.34E-03 | 2.67E-04 | 5.15E-02 | 5.28E-02 | 5.18E-02 | |
| SBT-6 | 6.51E-06 | 3.91E-07 | 3.86E-03 | 7.72E-04 | 5.00E-02 | 5.39E-02 | 5.08E-02 | |
| SBT-7 | 6.41E-06 | 3.84E-07 | 3.00E-03 | 6.01E-04 | 2.26E-01 | 2.29E-01 | 2.27E-01 | |
| SBT-8 | 3.80E-06 | 2.28E-07 | 3.31E-03 | 6.62E-04 | 1.41E-02 | 1.74E-02 | 1.48E-02 | |
| SBT-9 | 7.91E-06 | 4.75E-07 | 2.30E-03 | 4.60E-04 | 1.14E-01 | 1.16E-01 | 1.14E-01 | |
| SBT-10 | 4.85E-04 | 2.91E-05 | 2.90E-03 | 5.80E-04 | 1.66E-02 | 2.00E-02 | 1.72E-02 | |
| SBT-11 | 7.32E-03 | 4.39E-04 | 3.08E-03 | 6.16E-04 | 4.92E-02 | 5.96E-02 | 5.03E-02 | |
| SBT-12 | 4.84E-03 | 2.91E-04 | 1.12E-03 | 2.23E-04 | 7.58E-02 | 8.18E-02 | 7.63E-02 | |
| SBT-13 | 9.57E-06 | 5.74E-07 | 1.41E-03 | 2.83E-04 | 8.41E-02 | 8.55E-02 | 8.44E-02 | |
| SBT-14 | 5.53E-06 | 3.32E-07 | 2.38E-03 | 4.76E-04 | 9.32E-02 | 9.56E-02 | 9.37E-02 | |
| SBT-15 | 3.06E-06 | 1.83E-07 | 2.09E-03 | 4.19E-04 | 6.49E-02 | 6.70E-02 | 6.53E-02 | |
Fig. 1Relation between the concentration of heavy metal (μg/g) and price of smokeless (a) and smoke-based (b) tobacco products.
Fig. 2Concentration of Pb, Cd, and Cr in four types of tobacco products.